Whitnell & Co’s Integra LifeSciences IART Stock Holding History

Whitnell & Co’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-306	Closed	-$8K	–	251
2015 Q1	$8K	Hold	306	–	–	﹤0.01%	230
2014 Q4	$7K	Hold	306	–	–	﹤0.01%	245
2014 Q3	$6K	Hold	306	–	–	﹤0.01%	245
2014 Q2	$6K	Hold	306	–	–	﹤0.01%	251
2014 Q1	$6K	Hold	306	–	–	﹤0.01%	252
2013 Q4	$6K	Hold	306	–	–	﹤0.01%	243
2013 Q3	$5K	Hold	306	–	–	﹤0.01%	241
2013 Q2	$5K	Buy	+306	New	+$4.48K	﹤0.01%	339

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Whitnell & Co's IART Position: Q2 2015 in Review

Whitnell & Co sold out of Integra LifeSciences (IART) in Q2 2015, closing a stake of 306 shares — an estimated $8K sold.

Whitnell & Co first reported a position in IART in Q2 2013 and held it in 8 quarters. The position peaked at $8K in Q1 2015. 186 funds tracked by Wall St. Rank hold IART as of Q2 2015.

Whitnell & Co reported no remaining Integra LifeSciences position as of Q2 2015 after selling out during the quarter.
Whitnell & Co sold 306 Integra LifeSciences shares in Q2 2015, an estimated $8K.
Whitnell & Co first reported a position in Integra LifeSciences in Q2 2013 and held it in 8 quarters.
Whitnell & Co's Integra LifeSciences position peaked at $8K in Q1 2015.
186 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2015.

Based on Whitnell & Co's 13F filing for Q2 2015, filed 10 Aug 2015.